As featured in:

Clerisy has an experienced Board and Management team, national and international distribution relationships, proprietary medical delivery-device technology and a multi-faceted growth strategy focused on opportunities in the global consumer health market.

Better Medicine

Clerisy brings several key investment differentiators and competitive advantages to bear.

World Renowned Medical Expertise

Proprietary Medical Delivery Devices

Exit Strategy & Path To Liquidity

Mass Market Opportunity

Company Announcements  /  

Tycon Partners Announcement

RxMM and Clerisy announced that Clerisy has engaged Tycon Partners a Reg A+ Specialist operation based in Manhattan, New York to raise up to $25million in new capital to fund Clerisy’s product launch planned for Q2-17. » Download Tycon Partners Announcement (PDF)    

Company Announcements  /  

Acquisition by RxMM Health and IP Valuation

Clerisy announced that it has executed a binding Sale and Purchase Agreement to be acquired by RxMM Health Ltd of Perth Western Australia. » Download Acquisition by RxMM Health and IP Valuation (PDF)

Get in Touch

United States - New York

One Grove Street, Suite 217,
Pittsford, NY 14534

Tel: 1 (585) 348-9781

United States - California

31642 Coast Highway, Suite 202
Laguna Beach, CA, 92651

Tel: 1 (949) 456-3972

Last Issue Price


Price listed in USD.